rs10958827 PTPRD: viral peptide association

Key takeaways

  • This variant is linked to seropositivity for human alphaherpesvirus 1 peptide with a reported effect size of 5.68 and p=1e-8 in about 1 thousand individuals.
  • The association was found in a genome-wide study of this region.
  • No direct health outcome beyond the viral response is described.

Key takeaways

  • This variant is linked to seropositivity for human alphaherpesvirus 1 peptide twist_26201 with a reported effect size of 5.68 and p=1e-8 in about 1 thousand individuals.
  • The association was found in a genome-wide study of this region.
  • No direct health outcome beyond the viral response is described.

What the research says This variant is associated with seropositivity for human alphaherpesvirus 1 peptide twist_26201, reported effect size 5.68 p=1e-8 in about 1 thousand individuals [PMID 37164013]. The association was found in a genome-wide association study of this region [PMID 37164013].

Reported associations Seropositivity for human alphaherpesvirus 1 peptide twist_26201 this variant is associated with a reported effect size of 5.68 p=1e-8 in about 1 thousand individuals [PMID 37164013].

Evidence quality The study used a genome-wide association design on roughly 1000 participants, yielding an effect size of 5.68 and p=1e-8. No replication data are provided [PMID 37164013]. The evidence is limited to this single association.

No lifestyle considerations on file for this variant.

Frequently asked questions

What does rs10958827 mean?

It is a genetic change in the PTPRD gene that has been linked to seropositivity for human alphaherpesvirus 1 peptide. The study reports an effect size of 5.68 and p=1e-8.

Is this variant related to health problems?

The research only shows a link to the viral response, not any disease or condition.

Can I change my risk with lifestyle?

There is no evidence that lifestyle changes affect this specific variant; it is described as a genetic association.